Survival time of secondary liver cancer
Feb 22, 2023
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
Secondary liver cancer, also known as liver metastasis, typically allows patients to survive for about six months, although some may live longer than five years. It is recommended to use ginsenoside Rh2 as an adjunctive treatment following chemotherapy. After surgery, patients should consume foods rich in protein and vitamins, ensure adequate sleep, avoid excessive fatigue, and maintain proper warmth.
The survival time for patients with secondary liver cancer is generally around six months.
Secondary liver cancer, also known as liver metastasis, refers to the condition in which a patient's primary cancer has advanced and spread to the liver. Due to the complex condition of these patients, poor physical health, and low tolerance for treatment, the overall prognosis tends to be poor, with an average survival of approximately six months. The nature of the primary tumor also plays a significant role. If the primary cancer can be completely treated, 5–40% of patients may achieve a survival rate of 20–40%. However, tumors with high malignancy and late detection, such as liver metastases from pancreatic cancer or gallbladder cancer, severely impact patient survival. Additionally, if there are metastases to other organs—such as bone or lung—the patient's life expectancy becomes even shorter, typically around three months.
It is recommended to use ginsenoside Rh2 as an adjunctive therapy after chemotherapy under a doctor’s guidance. After surgery, patients should consume foods rich in protein and vitamins, ensure adequate sleep, avoid excessive fatigue, and maintain proper warmth to prevent colds.
